TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity

RK Seth, S Das, D Dattaroy, V Chandrashekaran… - Free Radical Biology …, 2017 - Elsevier
NAFLD is a clinically progressive disease with steatosis, inflammation, endothelial
dysfunction and fibrosis being the stages where clinical intervention becomes necessary …
被引用次数：48 相关文章

TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity.

RK Seth, S Das, D Dattaroy… - Free Radical Biology …, 2016 - europepmc.org
NAFLD is a clinically progressive disease with steatosis, inflammation, endothelial
dysfunction and fibrosis being the stages where clinical intervention becomes necessary …

[引用][C] TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity

RK Seth, S Das, D Dattaroy… - Free Radical Biology …, 2017 - cir.nii.ac.jp
TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by
blocking CYP2E1-mediated redox toxicity | CiNii Research CiNii 国立情報学研究所 学術情報 …

TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity

RK Seth, S Das, D Dattaroy… - Free Radical Biology …, 2017 - infona.pl
NAFLD is a clinically progressive disease with steatosis, inflammation, endothelial
dysfunction and fibrosis being the stages where clinical intervention becomes necessary …

TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity

RK Seth, S Das, D Dattaroy… - … radical biology & …, 2017 - pubmed.ncbi.nlm.nih.gov
NAFLD is a clinically progressive disease with steatosis, inflammation, endothelial
dysfunction and fibrosis being the stages where clinical intervention becomes necessary …
[HTML] nih.gov

[HTML][HTML] TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity

RK Seth, S Das, D Dattaroy… - Free radical biology & …, 2017 - ncbi.nlm.nih.gov
NAFLD is a clinically progressive disease with steatosis, inflammation, endothelial
dysfunction and fibrosis being the stages where clinical intervention becomes necessary …

TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity.

RK Seth, S Das, D Dattaroy… - Free Radical Biology …, 2016 - europepmc.org
NAFLD is a clinically progressive disease with steatosis, inflammation, endothelial
dysfunction and fibrosis being the stages where clinical intervention becomes necessary …